The current price of LZAGY is $82.12 — it has increased by 0.83% since the previous close. Data as of Nov 5, 2026.
LZAGY is up 4.61% over the past week, up 18.33% over the past month and up 23.47% over the past year. The price is above its 200-day moving average of $67.29.
Of the 3 analysts covering Lonza Group AG, 1 rates it a strong buy, 1 rates it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Lonza Group AG has a market capitalization of $58.43B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Yes. Lonza Group AG pays dividends annually. The latest payment of $0.5707 per share has a payment date of Jun 4, 2026, which corresponds to a dividend yield of 0.94%.
Companies most comparable to Lonza Group AG include Samsung Biologics Co.,Ltd., WuXi AppTec Co., Ltd., West Pharmaceutical Services, Inc., WuXi Biologics (Cayman) Inc. and Charles River Laboratories International, Inc.
In the latest trading session LZAGY moved between $81.82 and $82.58, a range of 0.93% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Lonza Group AG shows a strong buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Lonza Group AG is strong buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks LZAGY has traded between $58.53 and $82.58. The current price is 0.56% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.